Hansa Biopharma Welcomes Dr. Richard Philipson as Chief Medical Officer to Enhance Drug Development Strategy Hansa Biopharma has appointed Dr. Richard Philipson as Chief Medical Officer, bringing over 25 years of experience in drug development and clinical leadership.

Hansa Biopharma Welcomes Dr. Richard Philipson as Chief Medical Officer to Enhance Drug Development Strategy #Sweden #Lund #Hansa_Biopharma #Chief_Medical_Officer #Richard_Philipson